USP30 Inhibition as a Potential Therapy for Parkinson's Disease

Mutations in SNCA, the gene encoding α-synuclein (αSyn), cause familial Parkinson’s disease (PD) and aberrant αSyn is a key pathological hallmark of idiopathic PD. This α-synucleinopathy leads to mitochondrial dysfunction, which may drive dopaminergic neurodegeneration.

PARKIN and PINK1, mutated in autosomal recessive PD, regulate the preferential autophagic clearance of dysfunctional mitochondria (“mitophagy”) by inducing ubiquitylation of mitochondrial proteins, a process counteracted by deubiquitylation via USP30. Here we show that loss of USP30 in knockout mice protects against behavioral deficits and leads to increased mitophagy, decreased phospho-S129 αSyn, and attenuation of SN dopaminergic neuronal loss induced by αSyn. These observations were recapitulated with a potent, selective, brain-penetrant USP30 inhibitor, MTX115325, with good drug-like properties. These data strongly support further study of USP30 inhibition as a potential disease-modifying therapy for P

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A Place in the Sun presenter Jonnie Irwin hospitalized againJonnie Irwin, the presenter of A Place in the Sun, has been hospitalized again due to jaundice. He had previously revealed that he has terminal cancer. Despite his condition, he has been updating his followers on his treatment and spending time with his family. Unfortunately, he has now experienced another setback and is currently in the hospital.
Source: MetroUK - 🏆 13. / 82 Read more »